Morphic Holding EBIT

Morphic Holding (MORF) currently reports a EBIT of $-210M as of June 2024. That compares with $-140M in the prior-year period — down 49.1% year over year. That is below the Healthcare sector average of $22B. Use the charts on this page to explore Morphic Holding's EBIT history and peer comparisons.

Morphic Holding's EBIT decreased from $-140M to $-210M — a 49.1% year-over-year decrease (period ending June 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Morphic Holding's EBIT of $-210M is lower than the Healthcare sector average of $22B. That is roughly 101.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Morphic Holding reported $-210M in EBIT as of June 2024. That compares with $-140M in the prior-year period — down 49.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-210M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $22B. From there, open related valuation or income-statement pages for Morphic Holding, and consider following MORF for alerts when major investors trade the stock.